Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding

Detalhes bibliográficos
Autor(a) principal: Kurizky,Patricia Shu
Data de Publicação: 2015
Outros Autores: Ferreira,Clarissa de Castro, Nogueira,Lucas Souza Carmo, Mota,Licia Maria Henrique da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367
Resumo: Abstract Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.
id SBD-1_1130a3d20813dc11f24b5a2cc6036afd
oai_identifier_str oai:scielo:S0365-05962015000300367
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeedingArthritis, psoriaticLactationPregnancyPsoriasisAbstract Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.Sociedade Brasileira de Dermatologia2015-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367Anais Brasileiros de Dermatologia v.90 n.3 2015reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20153113info:eu-repo/semantics/openAccessKurizky,Patricia ShuFerreira,Clarissa de CastroNogueira,Lucas Souza CarmoMota,Licia Maria Henrique daeng2015-06-23T00:00:00Zoai:scielo:S0365-05962015000300367Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2015-06-23T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
title Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
spellingShingle Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
Kurizky,Patricia Shu
Arthritis, psoriatic
Lactation
Pregnancy
Psoriasis
title_short Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
title_full Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
title_fullStr Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
title_full_unstemmed Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
title_sort Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
author Kurizky,Patricia Shu
author_facet Kurizky,Patricia Shu
Ferreira,Clarissa de Castro
Nogueira,Lucas Souza Carmo
Mota,Licia Maria Henrique da
author_role author
author2 Ferreira,Clarissa de Castro
Nogueira,Lucas Souza Carmo
Mota,Licia Maria Henrique da
author2_role author
author
author
dc.contributor.author.fl_str_mv Kurizky,Patricia Shu
Ferreira,Clarissa de Castro
Nogueira,Lucas Souza Carmo
Mota,Licia Maria Henrique da
dc.subject.por.fl_str_mv Arthritis, psoriatic
Lactation
Pregnancy
Psoriasis
topic Arthritis, psoriatic
Lactation
Pregnancy
Psoriasis
description Abstract Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.
publishDate 2015
dc.date.none.fl_str_mv 2015-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20153113
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.90 n.3 2015
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126420266516480

Registros relacionados